Matthew G. Varga

980 total citations
33 papers, 641 citations indexed

About

Matthew G. Varga is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthew G. Varga has authored 33 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 11 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthew G. Varga's work include Helicobacter pylori-related gastroenterology studies (14 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Eosinophilic Esophagitis (6 papers). Matthew G. Varga is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (14 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Eosinophilic Esophagitis (6 papers). Matthew G. Varga collaborates with scholars based in United States, Germany and Sweden. Matthew G. Varga's co-authors include Richard M. Peek, Eric P. Skaar, Sudha Singh, Henry C. Lin, Amanda Carroll‐Portillo, Judith Romero–Gallo, M. Blanca Piazuelo, Joe Alcock, Carolina Bizama and Kurt Buchegger and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Oncogene.

In The Last Decade

Matthew G. Varga

31 papers receiving 636 citations

Peers

Countries citing papers authored by Matthew G. Varga

Since Specialization

Citations

This map shows the geographic impact of Matthew G. Varga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew G. Varga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew G. Varga more than expected).

Fields of papers citing papers by Matthew G. Varga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew G. Varga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew G. Varga. The network helps show where Matthew G. Varga may publish in the future.

Co-authorship network of co-authors of Matthew G. Varga

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew G. Varga. A scholar is included among the top collaborators of Matthew G. Varga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew G. Varga. Matthew G. Varga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract B046: Methylation based circulating tumor DNA serial monitoring correlates with immunotherapy response in non-small cell lung cancer 2024 ·Clinical Cancer Research ·Albert Hsiao, Brian Woodward, Patrick Ye, Matthew G. Varga, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gary A. Palmer, Hatim Husain	0
2	Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients 2022 ·Journal of Translational Medicine ·Robert S. Seitz, Michael E. Hurwitz, (unknown), Daniel Bailey, Matthew G. Varga, Brian Z. Ring, (unknown), Brock L. Schweitzer, Kimberly McGregor, Douglas T. Ross	7
3	27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer Study 2022 ·Clinical Lung Cancer ·David L. Saltman, Matthew G. Varga, (unknown), Nicole S. Croteau, (unknown), Amit Jain, Gregory A. Vidal, David R. Hout, Brock L. Schweitzer, Robert S. Seitz, Douglas T. Ross, David R. Gandara	2
4	Serum antibodies to selected Helicobacter pylori antigens are associated with active gastritis in patients seen at the University Teaching Hospital in Lusaka, Zambia 2022 ·Malawi Medical Journal ·Violet Kayamba, Julia Butt, Matthew G. Varga, Aaron Shibemba, M. Blanca Piazuelo, Keith T. Wilson, Kanekwa Zyambo, (unknown), (unknown), Tim Waterboer, Meira Epplein, Douglas C. Heimburger, Masharip Atadzhanov, Paul Kelly	4
5	Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer 2022 ·BMC Cancer ·(unknown), Amit Jain, (unknown), (unknown), (unknown), Emily J. Miller, (unknown), (unknown), Robert S. Seitz, David R. Hout, Matthew G. Varga, Brock L. Schweitzer, (unknown), (unknown), Douglas T. Ross, David R. Gandara, Gregory A. Vidal	7
6	Norepinephrine induces growth of Desulfovibrio vulgaris in an iron dependent manner 2022 ·Anaerobe ·(unknown), Matthew G. Varga, Joe Alcock, (unknown), Sudha Singh, Xiang Xue, Henry C. Lin	12
7	Intestinal Alkaline Phosphatase Prevents Sulfate Reducing Bacteria-Induced Increased Tight Junction Permeability by Inhibiting Snail Pathway 2022 ·Frontiers in Cellular and Infection Microbiology ·Sudha Singh, (unknown), Matthew G. Varga, Amanda Carroll‐Portillo, (unknown), Henry C. Lin	19
8	An immune-related gene expression profile to predict the efficacy of adding atezolizumab to first-line FOLFOXIRI plus bevacizumab in metastatic colorectal cancer: A translational analysis of the phase II randomized AtezoTRIBE study. 2022 ·Journal of Clinical Oncology ·Alessandra Boccaccino, (unknown), Mirella Giordano, Daniele Rossini, Margherita Ambrosini, Lisa Salvatore, Kimberly McGregor, Francesca Bergamo, Veronica Conca, Leonardo Provenzano, (unknown), (unknown), Giampaolo Tortora, Cosimo Rasola, (unknown), Alessandro Passardi, (unknown), Matthew G. Varga, Chiara Cremolini, Carlotta Antoniotti	1
9	Standard Bacteriophage Purification Procedures Cause Loss in Numbers and Activity 2021 ·Viruses ·Amanda Carroll‐Portillo, (unknown), Matthew G. Varga, Joe Alcock, Sudha Singh, Henry C. Lin	47
10	Notch Signaling Pathway Is Activated by Sulfate Reducing Bacteria 2021 ·Frontiers in Cellular and Infection Microbiology ·Sudha Singh, (unknown), Amanda Carroll‐Portillo, Matthew G. Varga, Henry C. Lin	22
11	5 CD274 (PD-L1) gene expression and the 27-gene immuno-oncology (IO) assay are associated with efficacy to immune checkpoint inhibitor treated patients with non-small cell lung cancer (NSCLC) 2021 ·Regular and Young Investigator Award Abstracts ·(unknown), Matthew G. Varga, (unknown), Douglas S. Ross, Brock L. Schweitzer, Robert S. Seitz, Gregory A. Vidal	2
12	Racial Differences in Helicobacter pylori CagA Sero-prevalence in a Consortium of Adult Cohorts in the United States 2020 ·Cancer Epidemiology Biomarkers & Prevention ·Matthew G. Varga, Julia Butt, William J. Blot, Loı̈c Le Marchand, Christopher A. Haiman, Yu Chen, Sylvia Wassertheil‐Smoller, Lesley F. Tinker, Richard M. Peek, John D. Potter, Timothy L. Cover, Terry Hyslop, Anne Zeleniuch‐Jacquotte, Sonja I. Berndt, Allan Hildesheim, Tim Waterboer, Michael Pawlita, Meira Epplein	25
13	Immunostimulatory membrane proteins potentiate H. pylori -induced carcinogenesis by enabling CagA translocation 2020 ·Gut Microbes ·Matthew G. Varga, (unknown), Julia Butt, (unknown), Wei‐Cheng You, Kai‐Feng Pan, Tim Waterboer, Meira Epplein, Carrie L. Shaffer	6
14	Smoking, Helicobacter Pylori Serology, and Gastric Cancer Risk in Prospective Studies from China, Japan, and Korea 2019 ·Cancer Prevention Research ·Julia Butt, Matthew G. Varga, Tianyi Wang, Shoichiro Tsugane, Taichi Shimazu, Wei Zheng, Christian C. Abnet, Keun‐Young Yoo, Sue K. Park, Jeongseon Kim, Sun Ha Jee, You‐Lin Qiao, Xiao‐Ou Shu, Tim Waterboer, Michael Pawlita, Meira Epplein	42
15	Epstein–Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia 2018 ·Digestive Diseases and Sciences ·Matthew G. Varga, Hui Cai, Tim Waterboer, Gwen Murphy, Taichi Shimazu, Phil R. Taylor, You‐Lin Qiao, Sue K. Park, Keun-Young Yoo, Sun Ha Jee, Eo Rin Cho, Jeongseon Kim, Christian C. Abnet, Shoichiro Tsugane, Qiuyin Cai, Wei Zheng, Michael Pawlita, Xiao‐Ou Shu, Meira Epplein	11
16	DNA Transfer and Toll-like Receptor Modulation by Helicobacter pylori 2017 ·Current topics in microbiology and immunology ·Matthew G. Varga, Richard M. Peek	34
17	Genetic Evolution of aHelicobacter pyloriAcid-Sensing Histidine Kinase and Gastric Disease 2016 ·The Journal of Infectious Diseases ·Uma Krishna, Judith Romero–Gallo, Giovanni Suárez, (unknown), Andrzej M. Krezel, Matthew G. Varga, Mark H. Forsyth, Richard M. Peek	6
18	Pathogenic H elicobacter pylori strains translocate DNA and activate TLR9 via the cancer-associated cag type IV secretion system 2016 ·Oncogene ·Matthew G. Varga, Carrie L. Shaffer, Johanna C. Sierra, Giovanni Suárez, M. Blanca Piazuelo, (unknown), Judith Romero–Gallo, Uma Krishna, A. Delgado, Martín Alonso Gómez Zuleta, James A. D. Good, Fredrik Almqvist, Eric P. Skaar, P Corréa, Keith T. Wilson, Maria Hadjifrangiskou, Richard M. Peek	99
19	TLR9 activation suppresses inflammation in response to Helicobacter pylori infection 2016 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Matthew G. Varga, M. Blanca Piazuelo, Judith Romero–Gallo, Alberto G. Delgado, Giovanni Suárez, (unknown), Uma Krishna, (unknown), Eric P. Skaar, Keith T. Wilson, Holly M. Scott Algood, Richard M. Peek	35
20	miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway 2015 ·Cellular Oncology ·Ismael Riquelme, Óscar Tapia, Pamela Leal, Alejandra Sandoval, Matthew G. Varga, Pablo Letelier, Kurt Buchegger, Carolina Bizama, Jaime A. Espinoza, Richard M. Peek, Juan Carlos Araya, Juan Carlos Roa	105

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact